HK1048765A1 - 用於中耳外科手術的粘彈性物 - Google Patents

用於中耳外科手術的粘彈性物

Info

Publication number
HK1048765A1
HK1048765A1 HK03100886.4A HK03100886A HK1048765A1 HK 1048765 A1 HK1048765 A1 HK 1048765A1 HK 03100886 A HK03100886 A HK 03100886A HK 1048765 A1 HK1048765 A1 HK 1048765A1
Authority
HK
Hong Kong
Prior art keywords
viscoelastics
middle ear
ear surgery
surgical
surgery
Prior art date
Application number
HK03100886.4A
Other languages
English (en)
Inventor
R Jafari Masoud
Doshi Uday
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of HK1048765A1 publication Critical patent/HK1048765A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/14—Materials or treatment for tissue regeneration for ear reconstruction or ear implants, e.g. implantable hearing aids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
HK03100886.4A 2000-03-14 2003-02-07 用於中耳外科手術的粘彈性物 HK1048765A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18917900P 2000-03-14 2000-03-14
PCT/US2001/008064 WO2001068079A2 (en) 2000-03-14 2001-03-14 Viscoelastics for use in middle ear surgery

Publications (1)

Publication Number Publication Date
HK1048765A1 true HK1048765A1 (zh) 2003-04-17

Family

ID=22696258

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03100886.4A HK1048765A1 (zh) 2000-03-14 2003-02-07 用於中耳外科手術的粘彈性物

Country Status (13)

Country Link
US (1) US6632423B2 (zh)
EP (1) EP1267894B1 (zh)
JP (1) JP4746244B2 (zh)
AT (1) ATE466583T1 (zh)
AU (2) AU4741001A (zh)
BR (1) BR0109162A (zh)
CA (1) CA2402652C (zh)
DE (1) DE60142031D1 (zh)
ES (1) ES2343402T3 (zh)
HK (1) HK1048765A1 (zh)
MX (1) MXPA02008966A (zh)
WO (1) WO2001068079A2 (zh)
ZA (1) ZA200206696B (zh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2314049T3 (es) * 2001-02-15 2009-03-16 Access Pharmaceuticals, Inc. Formulaciones liquidas para la prevencion y el tratamiento de enfermedades y trastornos de la mucosa.
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US7820194B2 (en) * 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
US20040118414A1 (en) 2002-12-20 2004-06-24 Shah Mandar V Surface modified viscoelastics for ocular surgery
US7363928B2 (en) 2001-12-21 2008-04-29 Alcon, Inc. Dilution resistant viscoelastic compositions
DK1455750T3 (da) * 2001-12-21 2006-04-10 Alcon Inc Viscoelelastiske oftalmologiske sammensætninger, der omfatter hyaluronsyre og chondroitinsulfat
US8524213B2 (en) * 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
US20060003964A1 (en) * 2004-06-30 2006-01-05 Shah Mandar V Dilution resistant viscoelastic compositions
WO2006085987A2 (en) 2004-07-09 2006-08-17 University Of Iowa Research Foundation Rna interference in respiratory epitheial cells
US8313762B2 (en) * 2006-07-05 2012-11-20 Medtronic Xomed, Inc. Flexible bioresorbable hemostatic packing and stent
WO2009132228A1 (en) 2008-04-24 2009-10-29 Medtronic, Inc. Chitosan-containing protective composition
US9198997B2 (en) 2008-04-24 2015-12-01 Medtronic, Inc. Rehydratable thiolated polysaccharide particles and sponge
JP5833919B2 (ja) 2008-04-24 2015-12-16 メドトロニック，インコーポレイテッド キトサンと酸化多糖とに基づく保護用ゲル
JP5738753B2 (ja) * 2008-04-24 2015-06-24 メドトロニック，インコーポレイテッド 再水和可能な多糖粒子およびスポンジ
KR101534422B1 (ko) 2008-05-14 2015-07-09 오토노미, 인코포레이티드 귀 질환 치료를 위한 제어 방출형 코르티코스테로이드 조성물 및 방법
MX2011000862A (es) * 2008-07-21 2011-03-15 Otonomy Inc Composiciones antimicrobianas de liberacion controlada y metodos para el tratamiento de trastornos oticos.
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US10806833B1 (en) 2009-05-11 2020-10-20 Integra Lifesciences Corporation Adherent resorbable matrix
US9326943B1 (en) 2009-06-23 2016-05-03 Sandra M. Skovlund Biodegradable prosthesis
CA2825757C (en) * 2011-02-02 2019-09-03 The Charles Stark Draper Laboratory, Inc. Drug delivery apparatus
ES2444145T3 (es) 2011-11-24 2014-02-24 Quimera Ingeniería Biomédica, S.L. Complejo obtenido a partir de mezclas de ácido hialurónico o una sal del mismo y sulfato de condroitina
WO2015031393A1 (en) 2013-08-27 2015-03-05 Otonomy, Inc. Treatment of pediatric otic disorders
CN105903087A (zh) * 2015-12-14 2016-08-31 上海其胜生物制剂有限公司 一种兼具内聚性和弥散性的粘弹剂的制备方法
WO2018053173A1 (en) 2016-09-16 2018-03-22 Otonomy, Inc. Otic gel formulations for treating otitis externa
CN106821980B (zh) * 2017-02-17 2019-10-18 成都博创必成生物技术有限公司 一种鼻腔喷雾剂及其制备方法和生物阻隔膜
BR112022001674A2 (pt) 2019-07-31 2022-03-22 Astellas Pharma Inc Composição farmacêutica para administração por via otológica
CN114224609B (zh) * 2021-12-14 2024-01-30 曹佩培 一种中耳/咽鼓管防粘连膜及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US5166331A (en) 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US6051560A (en) 1986-06-26 2000-04-18 Nestle S.A. Chrondroitin sulfate/sodium hyaluronate composition
ES2064439T3 (es) * 1988-05-02 1995-02-01 Project Hear Material adhesivo quirurgico.
US5290552A (en) * 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
US5273056A (en) * 1992-06-12 1993-12-28 Alcon Laboratories, Inc. Use of combinations of viscoelastics during surgery
WO1994025004A1 (en) 1993-04-30 1994-11-10 Webb Bradford C Synthetic viscoelastic material for ophthalmic applications
US5501706A (en) 1994-11-29 1996-03-26 Wildflower Communications, Inc. Medical implant structure and method for using the same
US5811453A (en) * 1994-12-23 1998-09-22 Alcon Laboratories, Inc. Viscoelastic compositions and methods of use
US5972326A (en) 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
WO1997041899A1 (en) 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides

Also Published As

Publication number Publication date
CA2402652A1 (en) 2001-09-20
AU2001247410B2 (en) 2005-05-12
US6632423B2 (en) 2003-10-14
WO2001068079A3 (en) 2002-07-25
EP1267894B1 (en) 2010-05-05
MXPA02008966A (es) 2003-02-12
ATE466583T1 (de) 2010-05-15
JP4746244B2 (ja) 2011-08-10
JP2003534036A (ja) 2003-11-18
DE60142031D1 (de) 2010-06-17
CA2402652C (en) 2008-11-18
US20020169142A1 (en) 2002-11-14
WO2001068079A2 (en) 2001-09-20
ZA200206696B (en) 2003-08-21
BR0109162A (pt) 2005-01-11
AU4741001A (en) 2001-09-24
ES2343402T3 (es) 2010-07-30
EP1267894A2 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
ZA200206696B (en) Viscoelastics for use in middle ear surgery.
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
EP1485381B8 (en) Azolylaminoazine as inhibitors of protein kinases
AU2003220299A1 (en) Azinylaminoazoles as inhibitors of protein kinases
AU2003218215A1 (en) Azolylaminoazines as inhibitors of protein kinases
AU2003220300A1 (en) Compositions useful as inhibitors of protein kinases
CA2440764A1 (en) Combination of brimonidine and timolol for topical ophthalmic use
EP1600169A3 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
AU2003273276A1 (en) Methods and compositions for the preservation of cells, tissues or organs in the vitreous state
EP2497478A3 (en) Oligosaccaride compositions and use thereof in the treatment of infection
MXPA03007590A (es) Composiciones y metodos para mejorar suministro de droga a traves de y dentro de tejidos oculares.
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
FI956014A (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
WO2002008222A3 (en) HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS
TWI256896B (en) Combinations of viscoelastics for use during surgery
RS60604A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
AU2002341555A1 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
WO2002036096A8 (en) Non-aspirating transitional viscoelastics for use in surgery
HUP0204258A3 (en) Use of vitamin d-derivatives for preparation of pharmaceutical compositions useful in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
WO2005035746A3 (en) Medical use of tbk-1 or of inhibitors thereof
AU2003299468A1 (en) Dc-sign isoforms, related compositions and methods for their use in disease therapy
AU2003260566A1 (en) Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine
WO2004078761A8 (en) Enantiomerically pure cilazapril,process for preparation